Glial cells display a network of projections (cytonemes) which mediate cell to cell 
Introduction
Glioblastoma multiforme (GB) is the most frequent and aggressive primary malignant brain tumour with a 3 per 100.000 incidence per year [1] . GB patients´ median survival is 12-15 months, with less than 5% of survival after 5 years [1] [2] [3] [4] . The causes of GB are under debate [2] , 5% of the patients develop GB after a low grade astrocytoma [5] and the most frequent mutations include gain of function of EGFR (97%) and PI3K/AKT pathways (88%) [6] . The diagnosis, and therefore the treatment of GB, requires a mutations analysis taking into account the high frequency of clones within the same primary GB [7] . Temozolomide (TMZ) has emerged as an effective treatment for GB however, recent discoveries restrict the use of TMZ in GB patients depending on the methylation status of methylguanine DNA methytransferase (MGMT) [7] . Moreover, among other mutations, Isocitrate dehydrogenase (IDH) define the nature and features of GB [8] together with molecular alterations including 1p/10q deletions and tumour suppressor protein 53 (TP53) and alpha thalassemia/mental retardation (ATRX) mutations [8, 9] . This genetic and molecular heterogeneity difficult the diagnosis and treatment of this fatal brain tumours.
The recent discovery of an ultra-long tumour microtubes (TMs) network in GB [10] improves our understanding of GB progression and therapy resistance [11] . TMs are actin-based filopodia which infiltrate through the brain and reach long distances within the brain [10] . TMs are required in GB cells to mediate Wingless(Wg)/WNT signalling imbalance among neurons and GB cells. Wg/WNT signal is favoured in GB cells to promote proliferation, at expenses of the neurons which undergo degeneration and cause lethality [12, 13] . The central role of TMs in GB biology has emerged as a fundamental mechanism for GB rapid and lethal progression thus; it is an attractive field of study towards potential GB treatments. However, the molecular mechanisms underlying the expansion of TMs are not well understood and the signalling pathways mediating TM infiltration are still unknown.
Matrix metalloproteases (MMPs) are a family of endopeptidases capable of degrading the extracellular matrix (ECM). Members of the MMP family include the "classical" MMPs, the membrane-bound MMPs (MT-MMPs), the ADAMs (a disintegrin and metalloproteinase; adamlysins) and the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif). There are more than 20 members in the MMP and ADAMTS family including the collagenases, gelatinases, stromelysins, some elastases and aggrecanases [14] . The vertebrate MMPs have overlapping substrates, they exhibit genetic redundancy and compensation, and pharmacological inhibitors are non-specific.
In contrast, there are only two MMP genes in Drosophila, MMP1 and MMP2, categorized by their pericellular localization, as MMP1 is secreted and MMP2 is membraneanchored, suggesting that protein localization was the critical distinction in this small MMP family. Recent reports propose that products of both genes are found at the cell surface and released into media and that GPI-anchored MMPs promote cell adhesion when they are rendered inactive. Moreover, the two MMPs cleave different substrates, suggesting that this is the important distinction within this smallest MMP family [15] .
MMPs are upregulated in a number of tumours, including gliomas. MMPs upregulation in GB is associated with the diffuse infiltrative growth and have been proposed to play a role in glioma cell migration and infiltration [16, 17] reviewed in [18] . In consequence, MMPs upregulation in GB is an indicator of poor prognosis [19] and the study of the mechanisms mediated by MMPs is relevant for the biology of GB, and cancer in general.
The Jun-N-terminal Kinase (JNK) pathway has been associated to glial proliferation. GB cells normally activate JNK pathway to maintain the stem-like GB cells, which has become a pharmacological target for the treatment of GB [20] . Moreover, the JNK pathway is the main regulator of MMPs expression and cell motility in different organisms and tissues [21] [22] [23] [24] [25] .
In this study, we have used the Drosophila melanogaster model of glioma [26] to demonstrate that GB cells activate the JNK pathway and upregulate MMPs (MMP1 and 2) expression. MMPs contribute to TMs expansion through the brain and facilitate Frizzled1-mediated Wg/WNT signalling in GB cells. To complete the positive feedback loop, Wg/WNT signalling mediates JNK activation in GB cells to continue with the process. We postulate that the founder mutations in GB (PI3K and EGFR) initiate the process with the expansion of the TMs; afterwards, the system self-perpetuates (TMsFz1/Wg-JNK-MMPs-TMs) to facilitate GB progression and infiltration in the brain.
RESULTS

MMPs are upregulated in GB
GB cells tumour microtubes (TMs) infiltrate the brain and contribute to tumour progression and associated neurodegeneration [10, 13, 27] . TMs are actin-based structures similar to cytonemes [10, 13, 28] which mediate the exchange of signalling molecules among cells that contribute to GB advancement [13] . The mechanisms mediating TMs formation and progression are not well understood, we propose that TMs infiltration through the brain extracellular matrix (ECM) is mediated by Matrix Metalloproteases (MMPs) activity. To determine if MMPs are expressed in GB, we used specific antibodies and reporters to detect Drosophila MMP1 or MMP2 expression.
Confocal images show larvae brains stained with anti-MMP1 ( Figure 1A -B´´, E, F) or anti-MMP2 ( Figure S1A -B´´, E and a GFP reporter shown in F) signal increase in GB compared to control glial cells or to neighbouring neurons. To visualize the cytonemes (WT brain) or the TMs (GB samples) we use the specific marker ihog-RFP. MMPs proteins colocalize with TMs and are preferentially accumulated in the limiting region of GB and healthy brain tissue ( Figure 1B -B´´, S1B-B´´ and S1F-F´´). To determine the hierarchy of events between TMs formation and MMPs expression, we attenuated Gap43 expression in GB cells to prevent TMs formation and stained for MMPs. The results show that TMs do not expand upon Gap43 RNAi expression and MMP1 and MMP2 protein levels are comparable to control levels ( Figure 1C -C´´, E, F and S1C-C´´, E). Moreover, we reported recently that GB expansion requires Wg signaling, GB cells vampirize Wg from neighbouring neurons via Frizzled1 receptor (Fz1) accumulation in TMs. To determine Wg pathway contribution to MMP1/2 expression, we silenced Fz1 in GB to reduce Wg-pathway signaling and stained for MMPs. As previously reported, GB cells do not over proliferate; in addition MMP1 and MMP2 are not overexpressed upon Fz1 RNAi ( Figure 1D -D´´, E, F and S1D-D´´, E). All together the results suggest that MMP1 and MMP2 expression depend on TM network formation and Fz1-mediated Wg signalling pathway. These results indicate that GB cells form a TM network which facilitates Wg signalling and then, upregulate MMPs to mediate infiltration of glioma cells in the brain.
PI3K or EGFR individually do not stimulate MMPs expression
To determine the epistatic relations behind MMPs expression, we studied single gene modifications related to GB and the effect on MMPs. We expressed the constitutively active forms of PI3K (dp110) and EGFR (TOR-DER CA ) in glial cells marked with ihog-RFP. In both cases we did not observe an upregulation of MMP1 or the formation of TMs 
JNK activation in glioma
JNK is upregulated in a number of tumours including GB and it has been related to glioma malignancy [29] [30] [31] [32] . Moreover, JNK is a target for specific drugs in combination with temozolomide treatments as it was proven to play a central role in GB progression [20, [33] [34] [35] . However, little is known about the molecular mechanisms underlying JNK activation in glioma cells and the functional consequences for GB progression.
To confirm JNK pathway activation in GB cells, we used two independent reporters. pucLacZ monitors the transcriptional activation of the downstream JNK target puckered [36, 37] in addition, Tre-GFP confer transcriptional activation in response to JNK signalling [38] [39] [40] . GB cells show a progressive upregulation of puc-LacZ ( 
Grindelwald receptor mediates GB progression
Next we decipher the molecular basis of JNK pathway activation in GB cells. eiger (egr)
is the ligand for JNK-grnd pathway, to determine the localization of we used a egr-GFP protein fusion and monitored GFP signal in confocal images. The results show that GFP signal is localized in the neurons that contact with glial cells and the egr-GFP signal is higher in GB samples ( Figure S3A -E). Next we monitored the expression pattern of the JNK receptor Grindelwald (grnd), we used a specific antibody in GB and control samples ( Figure S3F-H) . The results show that grnd protein accumulation in glial membranes is increased in GB brains. Taking these data together, GB cells increase the amount of grnd and egr protein is upregulated in the tissues surrounding GB cells.
To study the contribution of grnd to GB progression, we attenuated grnd expression with ) [41] in GB cells ( Figure S5 ). The results show that JNK pathway is necessary to localize Fz1 in the TMs and promote GB progression
Next we studied the activation of Wg signalling pathway in glia and GB cells. Armadillo (Arm) is the orthologue of mammalian β-catenin which translocate to the nuclei to activate transcription of target genes upon Wg-Fz1 signalling [13, 42] . We used an specific antibody (Cyt-Arm) which detects the inactive form of Arm [13, 42] 
JNK triggers MMPs expression in GB
The mechanisms for TMs progression and GB cells infiltration through the brain are not well understood. GB cells project TMs which cross the extracellular matrix (ECM) and break in the brain to reach territories distant from the original GB site. We propose that JNK activity in GB mediate the production of matrix metalloproteinases (MMPs) to facilitate ECM digestion and, as a consequence, permit TMs infiltration through the brain.
To validate this hypothesis, we first determined if MMPs expression in GB (Figure 1 , Figure 7A -B´´) depends on grnd and JNK pathway signalling. We generated a GB and silenced JNK pathway with Bsk DN ( Figure 7C -C´´) or silenced grnd expression ( Figure   7D -E´´). The quantification of MMP1 signal showed that GB upregulation of MMP1 is prevented after JNK pathway silencing ( Figure 7F ). As occurs in epithelial cells, MMP1
is a target of JNK pathway also in GB cells.
TMs expansion requires MMPs
Matrix metalloproteinases (MMPs) are extracellular enzymes responsible for the degradation of the extracellular matrix; cancer cells produce MMPs to facilitate tumour progression and invasiveness. MMPs are upregulated in human GBM cell-lines and biopsies as compared with low-grade astrocytoma (LGA) and normal brain samples [43, 44] . In particular, among the 23 MMPs present in humans, MMP9, MMP2 and MMP14
are directly implicated in growth and invasion of GB cells [45] .
WNT induces MMPs expression during development and cancer [46] [47] [48] [49] [50] To determine the contribution of MMPs to the lethality caused by GB, we downregulated MMP1 or MMP2 in GB samples and analyzed survival. To avoid developmental defects caused by MMP1 or MMP2 attenuation, we did the survival experiments after metamorphosis, in adults. We used the Gal80 TS system to silence the binary expression system UAS/Gal4 during development, and switched it on 4 days after eclosion. Glioma lethality was rescued by MMP1 or MMP2 down regulation ( Figure 8I ) suggesting that
MMPs are required for GB lethality. All the data together suggest that MMPs facilitate infiltration and tumour invasiveness in the brain, mediate Wg pathway imbalance, GB cells increase and TMs projection which induce premature death.
GB causes neurodegeneration and neurological symptoms in patients [55] . We have previously described that in GB brains TMs expansion and therefore the accumulation of Fz1 in the projections is having an effect on the neighbouring neurons that accumulate inactive Arm [13] . Moreover, it has been reported that reduction in Wg signalling causes reduction of synapse number, which is one of the initial events in neurodegeneration [56] [57] [58] [59] . We wondered if MMPs role in GB would reduce the synapse number in our animal model. We specifically inhibited MMP1 or MMP2 in GB and quantified the number of active zones in neuromuscular junctions. The results showed a significant reduction in the number of synapses in the neurons upon GB induction compared with the control (Figure 9A-B) . However, upon MMP1 or MMP2 knockdown in GB, neurons are protected and the number of active zones is rescued (Figure 9D , F, G).
Taking all these data together, we showed that MMPs mediate GB progression and neurodegeneration. Further, MMPs silencing in GB cells is sufficient to rescue life spam in adult flies. These results bring a novel positive feedback loop among Wg pathway, JNK and MMPs which contribute to GB development ( Figure 9H ), thus opening novel avenues for GB adaptation mechanisms and potential pharmacological targets.
Discussion
Activating mutations for EGFR and PI3K pathways are the most frequent initial signals in GB. However, the attempts to treat GB reducing the activation of these pathways have so far been limited by acquired drug resistance. The current tendencies suggest that a multiple approach is required to obtain a more positive result [60] [61] [62] [63] [64] . GB cells show a high mutation rate and usually present more than two sub-clones within the same patient and from the same primary tumour [65, 66] .
Here we describe that JNK signalling regulates MMPs expression in GB, which is required for TMs network formation and infiltration. As a consequence, Wg pathway responds to JNK and TMs expansion, these three events conform a regulatory positive feedback loop in GB progression ( Figure 9H ). Grnd is the JNK receptor upregulated in GB cells, it binds to the ligand egr and activates JNK pathway. GFP fusion protein showed that egr is produced in the surrounding neurons and accumulated in the border of GB and healthy neuronal tissue. Therefore, here is another example of neuron-glia molecular interaction which mediates the physiological status of the brain and the evolution of GB. It is of interest to unravel the regulatory mechanisms that mediate egr expression and secretion in neurons as a potential modulator for brain tumour advance.
Frizzled receptors mediate matrix metalloproteinase (MMP) 2 and MMP9 expression in different scenarios. Blocking WNT signaling, or MMP activity, reduces T cell migration through the basement membrane in vitro and into inflamed skin in vivo. MMP promoters respond to WNT signalling through tandem TCF sites and mediate T cell extravasation [67] . MMP9 is a key molecular effector, downstream of HIF-1α and WNT activation, responsible for increased rates of neural stem cells proliferation and migration in hypoxia [68] . In addition, Mmp7 (also known as matrilysin) is a target gene of the Wnt signalling pathway in lung epithelial cells and is known to be a key mediator of pulmonary fibrosis [69] . Moreover, MMPs expression is associated to GB invasion, growth and angiogenesis [70, 71] . MMP2 and MMP9 co-silencing in combination with temozolomide treatment emerge as promising in the treatment against GB [72] . Furthermore, phase II clinical trials using the broad-spectrum MMP-inhibitor, marimastat, in conjunction with temozolomide has shown encouraging results [73] . Thus, the evidences suggest a central role for WNT pathway and specific MMPs in GB and emerge as promising targets for potential treatments [43] . 
Experimental Procedures
Fly stocks
Flies were raised in standard fly food at 25ºC. Fly stocks from the Bloomington stock
UAS-GFP (from BL25752), MMP2-GFP (BL60512). Fly stocks from the Vienna Drosophila Resource
Centre: [77] .
Drosophila glioblastoma model
The most frequent genetic lesions in human gliomas include mutation or amplification of the Epidermal Growth Factor Receptor (EGFR) gene. Glioma-associated EGFR mutant forms show constitutive kinase activity that chronically stimulates Ras signaling to drive cell proliferation and migration [78, 79] Other common genetic lesions include loss of the lipid phosphatase PTEN, which antagonizes the phosphatidylinositol-3 kinase (PI3K) signaling pathway, and mutations that activate PI3KCA, which encodes the p110a catalytic subunit of PI3K [98] [99] . Gliomas often show constitutively active Akt, a major PI3K
effector. However, EGFR-Ras or PI3K mutations alone are not sufficient to transform glial cells. Instead, multiple mutations that coactivate EGFR-Ras and PI3K/Akt pathways are required to induce a glioma [80] . In Drosophila, a combination of EGFR and PI3K mutations effectively causes a glioma-like condition that shows features of human gliomas including glia expansion, brain invasion, neuron dysfunction, synapse loss and neurodegeneration [26, 81, 82] . Moreover, this model has proved to be useful in finding new kinase activities relevant to glioma progression [83] To generate a glioma in Drosophila melanogaster adult flies, the Gal4/UAS system [84] was used as described above (repo-Gal4>UAS-EGFRλ,UAS-dp110. To restrict the expression of this genetic combination to the adulthood, we used the thermo sensitive repression system Gal80 TS .
Individuals maintained at 17ºC did not activate the expression of the UAS constructs, but when flies were switched to 29ºC, the protein Gal80 TS changed conformation and was not longer able to bind to Gal4 to prevent its interaction with UAS sequences, and the expression system was activated.
Antibodies for Immunofluorescence
Third-instar larval brains, were dissected in phosphate-buffered saline (PBS), fixed in 4%
formaldehyde for 30min, washed in PBS + 0.1 or 0.3% Triton X-100 (PBT), and blocked in PBT + 5% BSA. 
Western blots
For western blots, we used NuPAGE Bis-Tris Gels 4-12% (Invitrogen), and the following primary antibodies: mouse anti-MMP1 (DSHB 1:500) and mouse anti-tubulin (1:10,000
Sigma), we use Tubulin as a loading control instead of actin because the tumor microtubes are Actin positive and tubulin negative as previously described [10] . There were 3 biological replicates and Relative MMP1 Average pixel intensity was measured using measurement tool from Image Studio Lite Ver 5.2 and normalized against Tubulin.
Survival assay
Males Tub-Gal80; Repo-Gal4 were crossed with females bearing a control construct 
Imaging
Fluorescent labeled samples were mounted in Vectashield mounting media with DAPI (Vector Laboratories) and analyzed by Confocal microscopy (LEICA TCS SP5). Images were processed using Leica LAS AF Lite and Fiji (Image J 1.50e). Images were assembled using Adobe Photoshop CS5.1.
Quantifications
Relative Wg, Fz1, Cyt-Arm, TRE-RFP, grnd, MMP1 and MMP2 staining within brains was determined from images taken at the same confocal settings. Average pixel intensity was measured using measurement log tool from Fiji 1.51g and Adobe Photoshop CS5.1.
Average pixel intensity was measured in the glial tissue and in the adjacent neuronal tissue (N<10 for each sample in triplicates) and expressed as a Glia/Neuron ratio in all cases but Cyt-Arm that was expressed as Neuron/Glia ratio. Glial network volume was quantified using Imaris surface tool (Imaris 6.3.1 software).
For the co-localization of egr-GFP in glial cells, GFP channel volume was quantified using Imaris surface tool. We selected a specific threshold for the total volume in the control samples and then we applied these conditions to the analysis of the corresponding experimental sample. Then we applied a co-localization filter (intensity center of the red channel)
The number of Repo + cells, the number of synaptic active sites and the number of puclacZ positive cells was quantified by using the spots tool Imaris 6.3.1 software, we selected a minimum size and threshold for the puncta in the control samples of each experiment. Then we applied these conditions to the analysis of each corresponding experimental sample. For the puc-lacZ glia or neuron co-localization studies we quantified the total number of puc-lacZ + cells and then applied a co-localization filter (intensity center of the channel of interest) using the Spots tool from the Imaris 6.3.1
Bitplane Scientific Solutions software.
Statistical Analysis
To analyze and plot the data, we used Microsoft Excel 2013 and GraphPad Prism 6. We 
